๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Olanzapine versus amisulpride and placebo in the treatment of negative symptoms and deficit states of chronic schizophrenia

โœ Scribed by Y. Lecrubier; M. Bouhassira; V. Olivier; S. Lancrenon; A.M. Crawford


Book ID
118601508
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
176 KB
Volume
9
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Quetiapine versus olanzapine for the tre
โœ Pinkhas Sirota; Irit Pannet; Ady Koren; Eleonora Tchernichovsky ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB ๐Ÿ‘ 2 views

## Abstract Negative symptoms are considered the most debilitating and refractory aspect of schizophrenia, being associated with poor social, occupational and global outcomes. Conventional antipsychotics have limited efficacy against these symptoms and poor tolerability profiles. Atypical antipsych